Publication | Open Access

High concordance between immunohistochemistry and fluorescence in situ hybridization testing for HER2 status in breast cancer requires a normalized IHC scoring system

Her2 StatusImmunocytochemical TechniqueOncologyBreast OncologyCancer DetectionMedicinePathologyBreast ImagingBreast CancerBiomarker DiscoveryHigh ConcordanceMolecular DiagnosticsRadiation OncologyTumor Biology